• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Kaposi's Sarcoma After Autologous Stem-Cell Transplantation and Rituximab Treatment.
J Oncol Pract. 2018 Sep;14(9):565-568. doi: 10.1200/JOP.18.00246. Epub 2018 Jul 25.
2
Rituximab and DHAP followed by intensive therapy with autologous stem-cell transplantation as first-line therapy for mantle cell lymphoma.
Haematologica. 2006 Mar;91(3):425-6.
3
Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial.奥沙利铂在自体移植前联合大剂量阿糖胞苷和利妥昔单抗治疗套细胞淋巴瘤患者，比顺铂或卡铂提供更长的疾病控制时间：来自 LyMA 前瞻性试验的结果。
Bone Marrow Transplant. 2021 Jul;56(7):1700-1709. doi: 10.1038/s41409-020-01198-2. Epub 2021 Mar 3.
4
Counterpoint: The Role of Stem Cell Transplantation in Mantle Cell Lymphoma: The Pendulum Swings Again: Time to Reassess the Role of ASCT in First Complete Remission.反驳观点：干细胞移植在套细胞淋巴瘤中的作用：钟摆再次摆动：是时候重新评估自体干细胞移植在首次完全缓解中的作用了。
Oncology (Williston Park). 2016 Dec 15;30(12):1055, 1060-2.
5
Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.利妥昔单抗时代两种含卡莫司汀方案的比较：即使在高危患者中也有出色疗效。
Biol Blood Marrow Transplant. 2015 Nov;21(11):1926-31. doi: 10.1016/j.bbmt.2015.06.007. Epub 2015 Jun 16.
6
Bendamustine-rituximab in mantle cell lymphoma.苯达莫司汀-利妥昔单抗治疗套细胞淋巴瘤
Lancet Haematol. 2017 Jan;4(1):e2-e3. doi: 10.1016/S2352-3026(16)30187-9. Epub 2016 Dec 5.
7
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.套细胞淋巴瘤自体干细胞移植后利妥昔单抗的应用。
N Engl J Med. 2017 Sep 28;377(13):1250-1260. doi: 10.1056/NEJMoa1701769.
8
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.在年龄为 65 岁或以下的套细胞淋巴瘤（MCL Younger）患者中，在自体干细胞移植前给予高剂量阿糖胞苷联合免疫化疗：欧洲套细胞淋巴瘤网络的一项随机、开放标签、3 期试验。
Lancet. 2016 Aug 6;388(10044):565-75. doi: 10.1016/S0140-6736(16)00739-X. Epub 2016 Jun 14.
9
Rituximab maintenance significantly prolongs progression-free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation.利妥昔单抗维持治疗可显著延长采用北欧MCL2方案及自体干细胞移植治疗的新诊断套细胞淋巴瘤患者的无进展生存期。
Am J Hematol. 2019 Feb;94(2):E50-E53. doi: 10.1002/ajh.25362. Epub 2018 Dec 13.
10
Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study.鞘内注射利妥昔单抗、大剂量甲氨蝶呤以及R-DHAP方案序贯自体干细胞移植治疗继发性中枢神经系统淋巴瘤：HOVON 80二期研究结果
Hematol Oncol. 2017 Dec;35(4):497-503. doi: 10.1002/hon.2342. Epub 2016 Aug 17.

引用本文的文献

1
Rituximab-Induced Kaposi Sarcoma in HIV-Negative Patients: A Narrative Review.利妥昔单抗诱导的HIV阴性患者卡波西肉瘤：一项叙述性综述。
Cureus. 2023 Sep 16;15(9):e45365. doi: 10.7759/cureus.45365. eCollection 2023 Sep.

本文引用的文献

1
De Novo Human Herpesvirus 8 Tumors Induced by Rituximab in Autoimmune or Inflammatory Systemic Diseases.由自身免疫或炎症性系统性疾病中的利妥昔单抗诱导的新发性人类疱疹病毒 8 肿瘤。
Arthritis Rheumatol. 2017 Nov;69(11):2241-2246. doi: 10.1002/art.40217. Epub 2017 Oct 12.
2
Iatrogenic Kaposi's Sarcoma: a Retrospective Cohort Study in an Italian Tertiary Care Centre.医源性卡波西肉瘤：意大利一家三级护理中心的回顾性队列研究。
Clin Oncol (R Coll Radiol). 2017 Oct;29(10):e165-e171. doi: 10.1016/j.clon.2017.05.008. Epub 2017 Jun 10.
3
A case report of iatrogenic cutaneous Kaposi sarcoma due to rituximab therapy for thrombotic thrombocytopenic purpura.
Acta Oncol. 2017 Jan;56(1):111-113. doi: 10.1080/0284186X.2016.1253867. Epub 2016 Nov 25.
4
An Update on Kaposi's Sarcoma: Epidemiology, Pathogenesis and Treatment.卡波西肉瘤最新进展：流行病学、发病机制与治疗
Dermatol Ther (Heidelb). 2016 Dec;6(4):465-470. doi: 10.1007/s13555-016-0152-3. Epub 2016 Nov 1.
5
A case report of immunosuppression-related Kaposi's sarcoma after autologous stem cell transplantation.自体干细胞移植后免疫抑制相关卡波西肉瘤一例报告
BMC Res Notes. 2016 Mar 24;9:188. doi: 10.1186/s13104-016-1991-9.
6
Rituximab-containing Chemotherapy (R-CHOP)-induced Kaposi's Sarcoma in an HIV-negative Patient with Diffuse Large B Cell Lymphoma.含利妥昔单抗的化疗方案（R-CHOP）诱发一名HIV阴性弥漫性大B细胞淋巴瘤患者发生卡波西肉瘤。
Intern Med. 2015;54(24):3205-8. doi: 10.2169/internalmedicine.54.5103. Epub 2015 Dec 15.
7
Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient.在一名HHV8阳性、HIV阴性患者中，利妥昔单抗治疗使多中心Castleman病完全缓解后发生卡波西肉瘤。
Int J Hematol. 2010 Mar;91(2):347-8; author reply 349. doi: 10.1007/s12185-010-0497-9. Epub 2010 Feb 10.
8
Progression of classic Kaposi's sarcoma with rituximab.
J Am Acad Dermatol. 2005 Jul;53(1):155-7. doi: 10.1016/j.jaad.2004.12.048.
9
Kaposi's sarcoma in a child after autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Cancer. 1991 Sep 15;68(6):1361-4. doi: 10.1002/1097-0142(19910915)68:6<1361::aid-cncr2820680629>3.0.co;2-c.

Kaposi's Sarcoma After Autologous Stem-Cell Transplantation and Rituximab Treatment.

作者信息

Geller Shamir, Dickson Mark A, Busam Klaus J, Myskowski Patricia L

机构信息

Memorial Sloan Kettering Cancer Center; and Weill Cornell Medical College, New York, NY.

出版信息

J Oncol Pract. 2018 Sep;14(9):565-568. doi: 10.1200/JOP.18.00246. Epub 2018 Jul 25.

DOI:10.1200/JOP.18.00246
PMID:30044684
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6136896/
Abstract
摘要